Key result
The abstract provides background information on vasovagal syncope subtypes without reporting specific clinical outcomes for cardioneuroablation.
Case Report
Sequential cardioneuroablation may resolve recurrent VVS after initial failure; leaves open the role of repeat procedures pending controlled data.
Vasovagal syncope (VVS) is a common phenomenon, with upwards of 30%–45% of the population having suffered 1 VVS episode by the age of 60.1,2 It is a pathology that has frustrated many patients and providers in its suboptimal treatment response rate, and that has enacted an outsized economic impact on western societies.3 VVS subtypes are classified in 3 broad categories: a pure cardioinhibitory type (with and without asystole); a pure vasodepressor type, in which hypotension occurs without a significant decrease in heart rate (HR); and a mixed vasodepressor and cardioinhibitory type.
No takes yet. Share an insight, caveat, or question.
Thurber et al. (2022) conducted a case report in Vasovagal syncope. Cardioneuroablation was evaluated. The abstract provides background information on vasovagal syncope subtypes without reporting specific clinical outcomes for cardioneuroablation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: